Princeton Capital Management’s Cellectis CLLS Stock Holding History

Princeton Capital Management’s Portfolio CLLS Stock Details CLLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-10,594	Closed	-$24K	–	97
2022 Q3	$24K	Hold	10,594	–	–	0.01%	90
2022 Q2	$30K	Sell	10,594 -335	-3%	-$1.18K	0.01%	95
2022 Q1	$50K	Buy	+10,929	New	+$60.2K	0.02%	109
2021 Q4	–	Sell	-10,084	Closed	-$127K	–	114
2021 Q3	$127K	Sell	10,084 -504	-5%	-$6.98K	0.04%	108
2021 Q2	$164K	Buy	10,588 +531	+5%	+$8.93K	0.05%	106
2021 Q1	$203K	Hold	10,057	–	–	0.07%	99
2020 Q4	$272K	Sell	10,057 -1,468	-13%	-$32.9K	0.1%	85
2020 Q3	$213K	Hold	11,525	–	–	0.09%	87
2020 Q2	$205K	Buy	+11,525	New	+$175K	0.09%	89
2019 Q4	–	Sell	-1,855	Closed	-$19K	–	116
2019 Q3	$19K	Hold	1,855	–	–	0.01%	190
2019 Q2	$29K	Buy	+1,855	New	+$33.1K	0.01%	184

Other funds holding CLLS

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Princeton Capital Management's CLLS Position: Q4 2022 in Review

Princeton Capital Management sold out of Cellectis (CLLS) in Q4 2022, closing a stake of 10,594 shares — an estimated $24K sold.

Princeton Capital Management first reported a position in CLLS in Q2 2019 and held it in 11 quarters. The position peaked at $272K in Q4 2020. 40 funds tracked by Wall St. Rank hold CLLS as of Q4 2022.

Princeton Capital Management reported no remaining Cellectis position as of Q4 2022 after selling out during the quarter.
Princeton Capital Management sold 10,594 Cellectis shares in Q4 2022, an estimated $24K.
Princeton Capital Management first reported a position in Cellectis in Q2 2019 and held it in 11 quarters.
Princeton Capital Management's Cellectis position peaked at $272K in Q4 2020.
40 funds tracked by Wall St. Rank held Cellectis as of Q4 2022.

Based on Princeton Capital Management's 13F filing for Q4 2022, filed 31 Jan 2023.